AAOS2017: Triamcinonlone has higher rate of resolution for trigger finger vs dexamethasone
Triamcinolone vs. Dexamethasone Injection for Trigger Finger: A Randomized Controlled Trial
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
69 patients with trigger finger were randomized to treatment with either triamcinolone injection or dexamethasone injection. Patients were followed up at 6 weeks, 12 weeks, and 6 months for symptom resolution. Repeat injections were offered in cases of persistent or recurrent symptoms. During follow-up, fewer patients of the triamcinolone group required repeat injection compared to the dexamethaso...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE